These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 31463607

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Is compressed colchicine tablet superior to other colchicine preparations in patients with familial Mediterranean fever?
    Vasi İ, Kardaş RC, Yıldırım D, Kaya B, Duran R, Karadeniz H, Avanoğlu Güler A, Erden A, Küçük H, Göker B, Tufan A, Öztürk MA.
    Int J Clin Pharmacol Ther; 2024 Feb; 62(2):77-82. PubMed ID: 37969097
    [Abstract] [Full Text] [Related]

  • 4. Successful management of colchicine resistant familial Mediterranean fever patients with a standardized canakinumab treatment protocol: a case series and literature review.
    Eren Akarcan S, Dogantan S, Edeer Karaca N, Aksu G, Kutukculer N.
    Rheumatol Int; 2020 Jan; 40(1):161-168. PubMed ID: 31273456
    [Abstract] [Full Text] [Related]

  • 5. Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.
    Gül A.
    Best Pract Res Clin Rheumatol; 2016 Apr; 30(2):296-303. PubMed ID: 27886801
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Familial Mediterranean fever].
    Georgin-Lavialle S, Hentgen V, Stankovic Stojanovic K, Bachmeyer C, Rodrigues F, Savey L, Abbara S, Conan PL, Fraisse T, Delplanque M, Rouet A, Sbeih N, Koné-Paut I, Grateau G.
    Rev Med Interne; 2018 Apr; 39(4):240-255. PubMed ID: 29526329
    [Abstract] [Full Text] [Related]

  • 8. Does switching from coated colchicine to compressed colchicine improves treatment response in patients with familial Mediterranean fever?
    Öner N, Çelikel E, Tekin ZE, Güngörer V, Kurt T, Sezer M, Tekgöz N, Karagöl C, Coşkun S, Kaplan MM, Polat MC, Acar BÇ.
    Croat Med J; 2023 Oct 31; 64(5):354-361. PubMed ID: 37927190
    [Abstract] [Full Text] [Related]

  • 9. [Familial Mediterranean fever: not to be missed].
    Frenkel J, Bemelman FJ, Potter van Loon BJ, Simon A.
    Ned Tijdschr Geneeskd; 2013 Oct 31; 157(18):A5784. PubMed ID: 23635502
    [Abstract] [Full Text] [Related]

  • 10. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial.
    Hashkes PJ, Spalding SJ, Giannini EH, Huang B, Johnson A, Park G, Barron KS, Weisman MH, Pashinian N, Reiff AO, Samuels J, Wright DA, Kastner DL, Lovell DJ.
    Ann Intern Med; 2012 Oct 16; 157(8):533-41. PubMed ID: 23070486
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial.
    Koga T, Sato S, Miyamoto J, Hagimori N, Kawazoe Y, Arinaga K, Fukushima C, Yamamoto H, Kawakami A.
    Trials; 2018 Dec 29; 19(1):715. PubMed ID: 30594222
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MEFV gene compound heterozygous mutations in familial Mediterranean fever phenotype: a retrospective clinical and molecular study.
    Caglayan AO, Demiryilmaz F, Ozyazgan I, Gumus H.
    Nephrol Dial Transplant; 2010 Aug 29; 25(8):2520-3. PubMed ID: 19934083
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever.
    Gül A, Ozdogan H, Erer B, Ugurlu S, Kasapcopur O, Davis N, Sevgi S.
    Arthritis Res Ther; 2015 Sep 04; 17(1):243. PubMed ID: 26337145
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of long-term treatment with intravenous colchicine for familial Mediterranean fever (FMF) refractory to oral colchicine.
    Grossman C, Farberov I, Feld O, Livneh A, Ben-Zvi I.
    Rheumatol Int; 2019 Mar 04; 39(3):517-523. PubMed ID: 30604205
    [Abstract] [Full Text] [Related]

  • 16. Canakinumab treatment in four children with colchicine resistant familial mediterranean fever.
    Ozkan S, Atas B.
    J Pak Med Assoc; 2017 Jun 04; 67(6):945-947. PubMed ID: 28585601
    [Abstract] [Full Text] [Related]

  • 17. Subclinical inflammation in a case of menstruation-induced familial Mediterranean fever: A case report.
    Hara K, Endo Y, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Migita K, Kawakami A, Koga T.
    Medicine (Baltimore); 2018 Sep 04; 97(38):e12305. PubMed ID: 30235678
    [Abstract] [Full Text] [Related]

  • 18. Arterial stiffness in Familial Mediterranean Fever: correlations with disease-related parameters and colchicine treatment.
    Sgouropoulou V, Stabouli S, Trachana M.
    Clin Rheumatol; 2019 Sep 04; 38(9):2577-2584. PubMed ID: 31127463
    [Abstract] [Full Text] [Related]

  • 19. Discontinuing colchicine in symptomatic carriers for MEFV (Mediterranean FeVer) variants.
    Sönmez HE, Batu ED, Bilginer Y, Özen S.
    Clin Rheumatol; 2017 Feb 04; 36(2):421-425. PubMed ID: 27679472
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of intravenous Colchicine in children with Familial Mediterranean Fever.
    Tal R, Semo Oz R, Amarilyo G, Eidlitz-Marcus T, Goldberg O, Levinsky Y, Peled O, Harel L.
    Rheumatol Int; 2020 Jan 04; 40(1):121-128. PubMed ID: 31230112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.